Know Cancer

forgot password

Kid Cards: Teaching Kids About Medicines

7 Years
11 Years
Open (Enrolling)
Hemophilia, Sickle Cell Disease, Neoplasms, Blood Coagulation Disorders

Thank you

Trial Information

Kid Cards: Teaching Kids About Medicines

In 2004, then Surgeon General Carmona stated that a health literate individual is more apt
to know the answer, when asked how to keep themselves well (AHRQ, 2004). There is a
burgeoning movement among medical professionals to address health literacy. Teaching health
information to children will empower them to actively participate in their current care and
provide self-management skills that will assist them to keep themselves well throughout
their lives. Currently, few medication administration instructional cards exist that are
appropriate for children. Providing medication information that the child might understand
may result in better administration compliance, fewer adverse effects and develop an
individual that is knowledgeable regarding medications and appropriate administration. The
purpose if this research is to develop medication administration cards, appropriate for
children, which provide information on the most commonly used drugs among the
Hematology/Oncology population.

The overall objective of this research is to develop medication informational cards for
medications frequently used within the Hematology/Oncology pediatric population, and
evaluate the effectiveness of these cards, by means of a pre- and post–test.

Inclusion Criteria:

- Between the ages of 7 – 11 years

- Currently receiving disease management primarily coordinated through the
Hematology/Oncology section

- Receiving a medication identified as a variable for this study

- Are able to assent and have a parent/guardian who is willing to consent to study

- Suffer no apparent developmental difficulty that would prevent or make study
participation difficult

Exclusion Criteria:

- Individuals who cannot read or write English

- Individuals who are known to be non-compliant with medication routine and/or adhering
to follow-up visits.

Type of Study:


Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Educational/Counseling/Training

Outcome Measure:

Develop medication cards appropriate for children

Principal Investigator

Heather E Curry, RN, MSN

Investigator Role:

Principal Investigator

Investigator Affiliation:

Childrens Mercy Hospitals and Clinics


United States: Institutional Review Board

Study ID:

05 06-089E



Start Date:

August 2005

Completion Date:

December 2005

Related Keywords:

  • Hemophilia
  • Sickle Cell Disease
  • Neoplasms
  • Blood Coagulation Disorders
  • Medication Education
  • Pediatric
  • Anemia, Sickle Cell
  • Blood Coagulation Disorders
  • Hemostatic Disorders
  • Neoplasms
  • Hemophilia A



Childrens Mercy Hospitals and Clinics Kansas City, Missouri  64108